|
1
|
Wang L, Lu B, He M, Wang Y, Wang Z and Du
L: Prostate cancer incidence and mortality: Global status and
temporal trends in 89 countries from 2000 to 2019. Front Public
Health. 10:8110442022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Boorjian SA, Eastham JA, Graefen M,
Guillonneau B, Karnes RJ, Moul JW, Schaeffer EM, Stief C and Zorn
KC: A critical analysis of the long-term impact of radical
prostatectomy on cancer control and function outcomes. Eur Urol.
61:664–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Van den Broeck T, van den Bergh RCN, Arfi
N, Gross T, Moris L, Briers E, Cumberbatch M, De Santis M, Tilki D,
Fanti S, et al: Prognostic value of biochemical recurrence
following treatment with curative intent for prostate cancer: A
systematic review. Eur Urol. 75:967–987. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kasuya G, Ishikawa H, Tsuji H, Nomiya T,
Makishima H, Kamada T, Akakura K, Suzuki H, Shimazaki J, Haruyama
Y, et al: Significant impact of biochemical recurrence on overall
mortality in patients with high–risk prostate cancer after
carbon–ion radiotherapy combined with androgen deprivation therapy.
Cancer. 122:3225–3231. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Freedland SJ, Humphreys EB, Mangold LA,
Eisenberger M, Dorey FJ, Walsh PC and Partin AW: Risk of prostate
cancer–specific mortality following biochemical recurrence after
radical prostatectomy. JAMA. 294:433–439. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Venclovas Z, Stanionis M, Matjosaitis AJ
and Milonas D: Significance of time until PSA recurrence on
clinical progression of surgically treated high-risk prostate
cancer patients. Eur Urol Suppl.
18:e206910.1016/S1569-9056(19)31500-3. 2019. View Article : Google Scholar
|
|
7
|
Pak S, You D, Jeong IG, Kim YS, Hong JH,
Kim CS and Ahn H: Time to biochemical relapse after radical
prostatectomy and efficacy of salvage radiotherapy in patients with
prostate cancer. Int J Clin Oncol. 24:1238–1246. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Briganti A, Karnes RJ, Gandaglia G, Spahn
M, Gontero P, Tosco L, Kneitz B, Chun FK, Zaffuto E, Sun M, et al:
Natural history of surgically treated high-risk prostate cancer.
Urol Oncol. 33:163.e7–13. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pompe RS, Gild P, Karakiewicz PI, Bock LP,
Schlomm T, Steuber T, Graefen M, Huland H, Tian Z and Tilki D:
Long-term cancer control outcomes in patients with biochemical
recurrence and the impact of time from radical prostatectomy to
biochemical recurrence. Prostate. 78:676–681. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Garg H, Dursun F, Alsayegh F, Wang H, Wu
S, Liss MA, Kaushik D, Svatek RS and Mansour AM: Revisiting current
national comprehensive cancer network (NCCN) high-risk prostate
cancer stratification: A national cancer database analysis.
Prostate Cancer Prostatic Dis. 14:10.1038/s41391–022-00621-7.
2023.
|
|
11
|
Turkbey B, Rosenkrantz AB, Haider MA,
Padhani AR, Villeirs G, Macura KJ, Tempany CM, Choyke PL, Cornud F,
Margolis DJ, et al: Prostate imaging reporting and data system
version 2.1: 2019 Update of prostate imaging reporting and data
system version 2. Eur Urol. 76:340–351. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Buyyounouski MK, Choyke PL, McKenney JK,
Sartor O, Sandler HM, Amin MB, Kattan MW and Lin DW: Prostate
cancer-major changes in the American Joint Committee on Cancer
eighth edition cancer staging manual. CA Cancer J Clin. 67:245–253.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vollmer RT: Percentage of tumor in
prostatectomy specimens: A study of American Veterans. Am J Clin
Pathol. 131:86–91. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ito Y, Udo K, Vertosick EA, Sjoberg DD,
Vickers AJ, Al-Ahmadie HA, Chen YB, Gopalan A, Sirintrapun SJ,
Tickoo SK, et al: Clinical usefulness of prostate and tumor volume
related parameters following radical prostatectomy for localized
prostate cancer. J Urol. 201:535–540. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Otsuka M, Kamasako T, Uemura T, Takeshita
N, Shinozaki T, Kobayashi M, Komaru A and Fukasawa S: Factors
predicting biochemical recurrence after radical prostatectomy among
patients with clinical T3 prostate cancer. Jpn J Clin Oncol.
48:760–764. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Murata Y, Tatsugami K, Yoshikawa M,
Hamaguchi M, Yamada S, Hayakawa Y, Ueda K, Momosaki S and Sakamoto
N: Predictive factor of biochemical recurrence after radical
prostatectomy for high–risk prostate cancer. Int J Urol.
25:284–289. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nkengurutse G, Tian F, Jiang S, Wang Q,
Wang Y and Sun W: Preoperative predictors of biochemical
recurrence–free survival in high–risk prostate cancer following
radical prostatectomy. Front Oncol. 10:17612020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee KS, Koo KC, Choi IY, Lee JY, Hong JH,
Kim CS, Lee HM, Hong SK, Byun SS, Rha KH and Chung BH:
Re–stratification of patients with high–risk prostate cancer
according to the NCCN guidelines among patients who underwent
radical prostatectomy: An analysis based on the K–CaP registry.
Cancer Res Treat. 50:88–94. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
García-Barreras S, Nunes I, Srougi V,
Secin F, Baghdadi M, Sánchez-Salas R, Barret E, Rozet F, Galiano M
and Cathelineau X: Predictors of early, intermediate and late
biochemical recurrence after minimally invasive radical
prostatectomy in a single–centre cohort with a mean follow–up of 8
years. Actas Urol Esp (Engl Ed). 42:516–523. 2018.(In English,
Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cao L, Yang Z, Qi L and Chen M:
Robot–assisted and laparoscopic vs open radical prostatectomy in
clinically localized prostate cancer: Perioperative, functional,
and oncological outcomes: A Systematic review and meta–analysis.
Medicine (Baltimore). 98:e157702019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Preisser F, van den Bergh RCN, Gandaglia
G, Ost P, Surcel CI, Sooriakumaran P, Montorsi F, Graefen M, van
der Poel H, de la Taille A, et al: Effect of extended pelvic lymph
node dissection on oncologic outcomes in patients with D'Amico
intermediate and high risk prostate cancer treated with radical
prostatectomy: A multi–institutional study. J Urol. 203:338–343.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee CU, Lee SM, Chung JH, Kang M, Sung HH,
Jeon HG, Jeong BC, Seo SI, Jeon SS, Lee HM and Song W: Clinical
utility of prostate health index for diagnosis of prostate cancer
in patients with PI-RADS 3 lesions. Cancers (Basel). 14:41742022.
View Article : Google Scholar : PubMed/NCBI
|
